1. Home
  2. OLMA vs PANL Comparison

OLMA vs PANL Comparison

Compare OLMA & PANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • PANL
  • Stock Information
  • Founded
  • OLMA 2006
  • PANL 1996
  • Country
  • OLMA United States
  • PANL United States
  • Employees
  • OLMA N/A
  • PANL N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • PANL Marine Transportation
  • Sector
  • OLMA Health Care
  • PANL Consumer Discretionary
  • Exchange
  • OLMA Nasdaq
  • PANL Nasdaq
  • Market Cap
  • OLMA 299.7M
  • PANL 332.0M
  • IPO Year
  • OLMA 2020
  • PANL N/A
  • Fundamental
  • Price
  • OLMA $5.33
  • PANL $4.59
  • Analyst Decision
  • OLMA Strong Buy
  • PANL
  • Analyst Count
  • OLMA 4
  • PANL 0
  • Target Price
  • OLMA $24.50
  • PANL N/A
  • AVG Volume (30 Days)
  • OLMA 411.5K
  • PANL 192.5K
  • Earning Date
  • OLMA 08-05-2025
  • PANL 08-07-2025
  • Dividend Yield
  • OLMA N/A
  • PANL 4.29%
  • EPS Growth
  • OLMA N/A
  • PANL N/A
  • EPS
  • OLMA N/A
  • PANL 0.30
  • Revenue
  • OLMA N/A
  • PANL $554,589,579.00
  • Revenue This Year
  • OLMA N/A
  • PANL $4.72
  • Revenue Next Year
  • OLMA N/A
  • PANL $16.57
  • P/E Ratio
  • OLMA N/A
  • PANL $15.30
  • Revenue Growth
  • OLMA N/A
  • PANL 13.11
  • 52 Week Low
  • OLMA $2.86
  • PANL $3.93
  • 52 Week High
  • OLMA $16.62
  • PANL $7.50
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 66.85
  • PANL 35.51
  • Support Level
  • OLMA $4.40
  • PANL $4.90
  • Resistance Level
  • OLMA $5.36
  • PANL $5.20
  • Average True Range (ATR)
  • OLMA 0.29
  • PANL 0.15
  • MACD
  • OLMA 0.07
  • PANL -0.06
  • Stochastic Oscillator
  • OLMA 93.20
  • PANL 16.25

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About PANL Pangaea Logistics Solutions Ltd.

Pangaea Logistics Solutions Ltd and its subsidiaries provide seaborne drybulk logistics and transportation services. It transports various drybulk cargoes including grains, coal, iron, ore, pig, iron, hot briquetted iron, bauxite, alumina, cement clinker, dolomite, and limestone. The company provides ocean transportation services to clients utilizing an ocean-going fleet of motor vessels in the Handymax, Supramax, Ultramax, Panamax, and Post-Panamax segments. Its services include cargo loading, cargo discharge, vessel chartering, voyage planning, and technical vessel management. The company derives all of its revenues from contracts of affreightment, voyage charters and time charters. Geographically, it derives key revenue from the United States, followed by Canada, Germany, and others.

Share on Social Networks: